PersonBiotech
Pragathi Chandaluri
Author on MetaboCovid-19: Metabolomics and Artificial Intelligence for Precision Medicine in COVID-19 Management.
Public external IDs
Source-confirmed affiliation
No reviewed public affiliation edge is attached.
Topics
Outputs
MetaboCovid-19: Metabolomics and Artificial Intelligence for Precision Medicine in COVID-19 ManagementSourceEuropean Organization for Nuclear ResearchNano-Enable continous glucose monitoring: Translating nonosensors into regulated clinical solutionsSourceEuropean Organization for Nuclear ResearchNano-Enable continous glucose monitoring: Translating nonosensors into regulated clinical solutionsSourceEuropean Organization for Nuclear ResearchMetaboCovid-19: Metabolomics and Artificial Intelligence for Precision Medicine in COVID-19 ManagementSourceEuropean Organization for Nuclear Research
Relationship evidence
MetaboCovid-19: Metabolomics and Artificial Intelligence for Precision Medicine in COVID-19 Management
MetaboCovid-19: Metabolomics and Artificial Intelligence for Precision Medicine in COVID-19 Management
Nano-Enable continous glucose monitoring: Translating nonosensors into regulated clinical solutions
Nano-Enable continous glucose monitoring: Translating nonosensors into regulated clinical solutions
Nano-Enable continous glucose monitoring: Translating nonosensors into regulated clinical solutions
Nano-Enable continous glucose monitoring: Translating nonosensors into regulated clinical solutions
MetaboCovid-19: Metabolomics and Artificial Intelligence for Precision Medicine in COVID-19 Management
MetaboCovid-19: Metabolomics and Artificial Intelligence for Precision Medicine in COVID-19 Management